The changes induced by cyclophosphamide in intestinal barrier and microflora in mice

European Journal of Pharmacology

Volumn 714, Issue 1-3, 2013, Pages 120-124

  Yang, Jin ^a,b   Liu, Kai Xiong ^c   Qu, Jie Ming ^c   Wang, Xiao Dan ^a  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c HUADONG HOSPITAL AFFILIATED TO FUDAN UNIVERSITY   (China)

Author keywords

Bacterial translocation; Cyclophosphamide; Intestinal microflora; Tight junction

Indexed keywords

CYCLOPHOSPHAMIDE; OCCLUDIN; PROTEIN ZO1; TUBULIN; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL TRANSLOCATION; CELL JUNCTION; CONTROLLED STUDY; DRUG MEGADOSE; ENTEROBACTERIACEAE; ENTEROCOCCUS; ESCHERICHIA COLI; INTESTINE BARRIER; INTESTINE FLORA; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS; TIGHT JUNCTION;

BACTERIAL TRANSLOCATION; CYCLOPHOSPHAMIDE; INTESTINAL MICROFLORA; TIGHT JUNCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; CADHERINS; CYCLOPHOSPHAMIDE; GENE EXPRESSION REGULATION; INTESTINAL MUCOSA; INTESTINES; MALE; MICE; MICE, INBRED BALB C; MICROBIOTA; OCCLUDIN; PERMEABILITY; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84880181418     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.06.006     Document Type: Article

References (24)

1. Balzan, S., de Almeida Quadros, C., de Cleva, R., Zilberstein, B., Cecconello, I., 2007. Bacterial translocation: overview of mechanisms and clinical impact. J. Gastroenterol. Hepatol. 22, 464-471. (Pubitemid 46435001)
2. Basuroy, S., Sheth, P., Mansbach, C.M., Rao, R.K., 2005. Acetaldehyde disrupts tight junctions and adherens junctions in human colonic mucosa: protection by EGF and L-glutamine. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G367-G375. (Pubitemid 41022764)
3. Bengmark, S., 2012. Pro- and Syn-biotics to prevent sepsis in major surgery and severe emergencies. Nutrients 4, 91-111.
4. Chen, L.W., Wang, J.S., Hwang, B., Chen, J.S., Hsu, C.M., 2003. Reversal of the effect of albumin on gut barrier function in burn by the inhibition of inducible isoform of nitric oxide synthase. Arch. Surg. 138, 1219-1225. (Pubitemid 37392396)
5. Corridoni, D., Pastorelli, L., Mattioli, B., Locovei, S., Ishikawa, D., Arseneau, K.O., Chieppa, M., Cominelli, F., Pizarro, T.T., 2012. Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism. PLoS One 7, e42067.
6. Costantini, T.W., Loomis, W.H., Putnam, J.G., Drusinsky, D., Deree, J., Choi, S., Wolf, P., Baird, A., Eliceiri, B., Bansal, V., Coimbra, R., 2009. Burn-induced gut barrier injury is attenuated by phosphodiesterase inhibition: effects on tight junction structural proteins. Shock (Augusta, GA) 31, 416-422.
7. Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S.R., Nelson, K.E., Relman, D.A., 2005. Diversity of the human intestinal microbial flora. Science 308, 1635-1638. (Pubitemid 40807514)
8. Gu, L., Li, N., Gong, J., Li, Q., Zhu, W., Li, J., 2011. Berberine ameliorates intestinal epithelial tight-junction damage and down-regulates myosin light chain kinase pathways in a mouse model of endotoxinemia. J. Infect. Dis. 203, 1602-1612.
9. Ishikawa, H., Kutsukake, E., Fukui, T., Sato, I., Shirai, T., Kurihara, T., Okada, N., Danbara, H., Toba, M., Kohda, N., Maeda, Y., Matsumoto, T., 2010. Oral administration of heat-killed Lactobacillus plantarum strain b240 protected mice against Salmonella enterica serovar Typhimurium. Biosci. Biotechnol. Biochem. 74, 1338-1342.
10. Matsumoto, T., Ishikawa, H., Tateda, K., Yaeshima, T., Ishibashi, N., Yamaguchi, K., 2008. Oral administration of bifidobacterium longum prevents gut-derived Pseudomonas aeruginosa sepsis in mice. J. Appl. Microbiol. 104, 672-680. (Pubitemid 351257734)
11. Morrow, L.E., Gogineni, V., Malesker, M.A., 2012. Probiotics in the intensive care unit. Nutr. Clin. Pract. 27, 235-241.
12. Shimizu, K., Ogura, H., Goto, M., Asahara, T., Nomoto, K., Morotomi, M., Yoshiya, K., Matsushima, A., Sumi, Y., Kuwagata, Y., Tanaka, H., Shimazu, T., Sugimoto, H., 2006. Altered gut flora and environment in patients with severe SIRS. J. Trauma 60, 126-133.
13. Song, D., Shi, B., Xue, H., Li, Y., Yang, X., Yu, B., Xu, Z., Liu, F., Li, J., 2006a. Confirmation and prevention of intestinal barrier dysfunction and bacterial translocation caused by methotrexate. Dig. Dis. Sci. 51, 1549-1556. (Pubitemid 44379296)
14. Song, D., Shi, B., Xue, H., Li, Y., Yu, B., Xu, Z., Liu, F., Li, J., 2006b. Green fluorescent protein labeling Escherichia coli TG1 confirms intestinal bacterial translocation in a rat model of chemotherapy. Curr. Microbiol. 52, 69-73. (Pubitemid 43142801)
15. Sonis, S.T., Oster, G., Fuchs, H., Bellm, L., Bradford, W.Z., Edelsberg, J., Hayden, V., Eilers, J., Epstein, J.B., LeVeque, F.G., Miller, C., Peterson, D.E., Schubert, M.M., Spijkervet, F.K., Horowitz, M., 2001. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J. Clin. Oncol. 19, 2201-2205. (Pubitemid 32372323)
16. Southcott, E., Tooley, K.L., Howarth, G.S., Davidson, G.P., Butler, R.N., 2008. Yoghurts containing probiotics reduce disruption of the small intestinal barrier in methotrexate-treated rats. Dig. Dis. Sci. 53, 1837-1841.
17. Stecher, B., Hardt, W.D., 2008. The role of microbiota in infectious disease. Trends Microbiol. 16, 107-114.
18. Ulluwishewa, D., Anderson, R.C., McNabb, W.C., Moughan, P.J., Wells, J.M., Roy, N.C., 2011. Regulation of tight junction permeability by intestinal bacteria and dietary components. J. Nutr. 141, 769-776.
19. van Vliet, M.J., Harmsen, H.J., de Bont, E.S., Tissing, W.J., 2010. The role of intestinal microbiota in the development and severity of chemotherapy-induced muco-sitis. PLoS Pathog. 6, e1000879.
20. van Vliet, M.J., Tissing, W.J., Dun, C.A., Meessen, N.E., Kamps, W.A., de Bont, E.S., Harmsen, H.J., 2009. Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clin. Infect. Dis. 49, 262-270.
21. Wada, M., Nagata, S., Saito, M., Shimizu, T., Yamashiro, Y., Matsuki, T., Asahara, T., Nomoto, K., 2010. Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies. Support Care Cancer 18, 751-759.
22. Wiest, R., Rath, H.C., 2003. Bacterial translocation in the gut. Best Pract. Res. Clin. Gastroenterol. 17, 397-425.
23. Zhang, C., Xu, Y.-G., Duan, X.-N., Liu, Y.-H., Zhao, J.-X., Xu, L., Ye, J.-M., 2011. Role of granulocyte colony-stimulating factor in paclitaxel-induced intestinal barrier breakdown and bacterial translocation in rats. Chin. Med. J. 124, 1870-1875.
24. Zhao Yiqing, L.X., Chen, Dong-hui, Meng-yao, Yu, Yang, Zhi-rong, 2005. Comparison of immunosuppression induced by different dose of cyclophosphamide in normal mice. Immunol. J. 21, S122-S124.